Skip to main content
EMV CAPITAL PLC logo

EMV CAPITAL PLC — Investor Relations & Filings

Ticker · EMVC ISIN · GB00BN4R5Q82 LEI · 213800N5WD46G1Y7I458 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2018-11-27 M&A Activity
Country GB United Kingdom
Listing IL EMVC

About EMV CAPITAL PLC

https://www.emvcapital.com/

EMV Capital PLC is a venture capital investment group specializing in deep tech and life sciences. The firm identifies, invests in, and builds high-growth, IP-rich companies with an international portfolio, focusing on sectors including industrial technology, healthcare, and sustainability. It employs a capital-efficient investment strategy that combines syndicated investments, direct balance sheet funding, and managed funds to support companies from their early stages through to successful exit. EMV Capital engages in proactive portfolio management, often taking board positions and working closely with company leadership. It provides extensive value creation services, including support for fundraising, exit readiness, IP strategy, and corporate collaborations, to drive growth and maximize returns for investors through strategic exits.

Recent filings

Filing Released Lang Actions
Form 8.5 - NetScientific PLC
M&A Activity Classification · 100% confidence The document is a 'Form 8.5 (EPT/NON-RI)' filed under the UK Takeover Code. This form is used by an Exempt Principal Trader to disclose positions and dealings in the securities of an offeror or offeree during a takeover or merger process. Since this document relates to M&A activity and specifically follows the regulatory requirements for takeover disclosures, it falls under the M&A Activity category.
2018-11-27 English
Form 8.3 - NetScientific PLC
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an M&A transaction. It details shareholdings and positions in NetScientific PLC. While it relates to M&A activity, it is specifically a 'Major Shareholding Notification' (MRQ) regarding the disclosure of significant interests, rather than a general M&A announcement (TAR).
2018-11-27 English
Amendment to Executive Director Service Terms
Regulatory Filings Classification · 98% confidence The document is an announcement from NetScientific PLC regarding amendments to the service terms of its Executive Directors (CEO and CFO) in the context of a formal sale process. This involves changes to executive compensation and retention incentives. While it touches on remuneration, it is primarily a management-related announcement regarding director service terms and related party transactions under AIM rules. Therefore, it fits best under 'Board/Management Information' (MANG).
2018-11-26 English
Announcement of Strategic Review
M&A Activity Classification · 98% confidence The document is an official announcement from NetScientific plc regarding a 'Strategic review including formal sale process under the Takeover Code'. This is a classic M&A-related announcement where a company initiates a formal sale process. While it mentions regulatory disclosures, the core subject matter is the initiation of a potential takeover or sale, which falls under the M&A Activity (TAR) category.
2018-11-26 English
PDS Announces Merger with Edge Therapeutics
M&A Activity Classification · 100% confidence The document is a press release announcing a definitive merger agreement between PDS Biotechnology and Edge Therapeutics. It details the terms of the all-share merger, the expected ownership structure, management changes, and the strategic rationale behind the transaction. As it pertains to a merger proposal and takeover-related activity, it falls under the M&A Activity category.
2018-11-26 English
Vortex Improves CTC Enumeration with Impedance
Regulatory Filings Classification · 98% confidence The document is a press release issued via the London Stock Exchange's Regulatory News Service (RNS). It announces a scientific study and technological advancement by a subsidiary (Vortex Biosciences) of the parent company (NetScientific PLC). It does not constitute a formal financial report, proxy, or governance document, but rather a corporate news update regarding business operations and R&D. As it is a general regulatory announcement that does not fit into more specific categories like M&A or Earnings, it is classified as an RNS.
2018-11-08 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.